Evidence map›Paper›PMID 34257138›Full record

ArticleBMJ global health2021

Drivers of antibiotic use in Vietnam: implications for designing community interventions.

Shannon McKinn, Duy Hoang Trinh, Dorothy Drabarek, Thao Thu Trieu, Phuong Thi Lan Nguyen, Thai Hung Cao, Anh Duc Dang, Thu Anh Nguyen, Greg J Fox, Sarah Bernays

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Shannon McKinnFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0001-6384-1745
Duy Hoang TrinhWoolcock Institute of Medical Research, Glebe, New South Wales, Australia.
Dorothy DrabarekFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Thao Thu TrieuWoolcock Institute of Medical Research, Glebe, New South Wales, Australia.
Phuong Thi Lan NguyenNational Insitute of Hygiene and Epidemiology, Ministry of Health, Hanoi, Vietnam.
Thai Hung CaoMedical Service Administration, Ministry of Health, Hanoi, Vietnam.
Anh Duc DangNational Insitute of Hygiene and Epidemiology, Ministry of Health, Hanoi, Vietnam.
Thu Anh NguyenFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Greg J FoxFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Sarah BernaysFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia sarah.bernays@sydney.edu.au.ORCID 0000-0001-7628-8408
The University of Sydney · AUNational Institute Of Hygiene And Epidemiology · VNWoolcock Institute of Medical Research · AUMinistry of Health · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAntimicrobial resistance is a global challenge that threatens our ability to prevent and treat common infectious diseases. Vietnam is affected by high rates of antimicrobial resistant infections, driven by the overuse of antibiotics and the Vietnamese government has recognised antimicrobial resistance as a health security priority. This study aimed to understand how people in Vietnam use antibiotics in community settings, and the factors that impact their practices and decision-making regarding antibiotics.

methodsWe conducted 43 qualitative in-depth interviews with 50 community members in two urban and two rural sites in Vietnam. We conducted iterative, inductive thematic analysis alongside data collection through a process of systematic debriefings based on detailed interview summaries. Through this process, we developed a coding framework that was then applied to transcribed interview data.

resultsFrequent and indiscriminate use of antibiotics was driven by the powerful appeal that antibiotics held for many Vietnamese consumers. Consumers were discerning in making decisions in their purchase and use of antibiotics. Consumers' decisions were affected by perceptions of what constitutes high-quality medicine (effective, strong, accessible and affordable); privileging symptom control over diagnosis; social constructions of antibiotics as a trusted remedy with embodied evidence of prior efficacy, which is reinforced by advice from trusted sources in their community; and varied, generally incomplete, understanding of the concept of antibiotic resistance and its implications for individuals and for public health.

conclusionAntibiotic use at the community and primary care level in Vietnam is driven by community members' social and economic response to what constitutes effective healthcare, rather than biomedical logic. Community-based interventions to reduce unnecessary antibiotic use need to engage with the entangled socio-structural factors that 'resist' current public health efforts to ration antibiotic use, alongside biomedical drivers. This study has informed the design of a community-based trial to reduce unnecessary antibiotic use.

Indexed as

Anti-Bacterial AgentsRural PopulationDrug Resistance, MicrobialHumansVietnamAnti-Bacterial Agentsdiseasesdisordershealth policyinfectionsinjuriespublic healthqualitative study

Identifiers

PMID34257138
PMCPMC8278923
OpenAlexW3180806622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.